Abiopharma

Theriva™ Biologics anuncia la próxima presentación de datos adicionales del ensayo clínico VIRAGE de Fase 2b del VCN-01 para el cáncer de páncreas metastásico en la Reunión Anual de la AACR de 2026

Meet the SWE Entrepreneurs Affinity Group Leadership Team — Part 1

ENPH Deadline: Rosen Law Firm Urges Enphase Energy, Inc. (NASDAQ: ENPH) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Zai Lab Presents New Preclinical Data Suggesting ZL-1503, an IL-13/IL-31Rα Bispecific Antibody, Provides Rapid Itch Relief and Reduction in Inflammation in Atopic Diseases

Nuvaxovid™ COVID-19 Vaccine Showed Better Tolerability than mNEXSPIKE in Head-to-head Sanofi-led Phase 4 Study

Kaskela Law Firm Announces Stockholder Investigation of HF Foods Group Inc. (HFFG) and Encourages HFFG Shareholders with Investment Losses to Contact the Firm

Communiqué de presse : ESCMID : Le Nuvaxovid, vaccin contre la COVID-19 de Sanofi, a montré une meilleure tolérance que le mNEXSPIKE dans une étude comparative directe

Press Release: ESCMID: Sanofis Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study

Other Report or Announcement

argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP